Bill > SB477

This bill, known as the "Sunshine in Savings Act," establishes comprehensive reporting requirements for hospitals and healthcare entities participating in the 340B Drug Pricing Program (a federal program that allows certain healthcare providers to purchase outpatient drugs at discounted prices). Starting April 1 each year, 340B covered entities must submit detailed annual reports to the state's Department of Health and Human Services, including the number of patients receiving discounted drugs, total drug acquisition and reimbursement costs, net revenues, charity care expenses, and government service contracts. The bill mandates that the department create a public, de-identified dashboard summarizing this information and requires hospitals to add claim-level identifiers to Medicaid claims to prevent duplicate discounts. Hospitals reporting over $2 million in 340B savings must also develop a rural patient benefit plan, and they are required to post plain-language notices about the 340B program and charity care policies on their websites. The legislation aims to increase transparency in how hospitals use the 340B program's drug pricing discounts, with potential enforcement through consumer protection laws if reporting requirements are not met. The bill is set to take effect on January 1, 2027, giving healthcare providers time to prepare for the new reporting standards.

Health and Social Services

https://gc.nh.gov/bill_Status/billinfo.aspx?id=1225&inflect=2